KKaroo Health provides technology-enabled cardiovascular care by partnering with health plans and cardiology practices to deliver value-based care. Its core offering is a digital platform powered by KohereAI that supports care management for cardiovascular conditions, helping clinicians monitor patients, coordinate care, and deploy evidence-based interventions. The platform is designed to improve patient outcomes while lowering the total cost of care, aligning incentives with value rather than sheer volume. The company differentiates itself through its proprietary KohereAI technology, a substantial network of cardiologists, and a focus on scaling value-based cardiovascular care across plans and practices, rather than competing on volume or fee-for-service models. Karoo Health’s goal is to shift the healthcare system toward value-based cardiovascular care, improving outcomes for patients while reducing overall costs.
Work here?Claim your company
Industries
Company Size
11-50
Company Stage
Series A
Total Funding
$19.6M
Headquarters
Albuquerque, New Mexico
Founded
2021
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$19.6M
Meets
Industry Average
Funded Over
2 Rounds
Industry standards
Karoo Health, a cardiovascular technology company, has appointed Angela Breton as chief commercial officer. Breton brings 25 years of healthtech experience to the newly created role, where she will develop partnerships across the sector to advance Karoo's mission of improving cardiac care through earlier detection and data-driven delivery. The appointment follows Karoo's $16.2 million Series A funding round in July, co-led by 7wire Ventures and Allumia Ventures. Breton's career spans revenue and commercial growth leadership roles, scaling payer, provider, and healthtech platforms. She has commercialised AI-powered clinical products and value-based care delivery models from early product-market fit to national scale. Karoo builds an operating system for cardiovascular care, connecting clinical, claims, pharmacy, and patient data to enable risk detection and coordinated treatment.
Karoo Health names industry pioneer Angela Breton as Chief Commercial Officer. Breton brings 25 years of healthtech experience and a track record of building strategic industry collaborations to Karoo's best-in-class management team DENVER, Oct. 6, 2026 /PRNewswire/ - Karoo Health, a cardiovascular technology company building an operating system supporting cardiac care, today announced the appointment of Angela "Angie" Breton as Chief Commercial Officer. Breton joins the company's executive leadership team in the newly created CCO role, where she will focus on developing partnerships across all of healthtech to further Karoo's mission to free people from the pain of cardiovascular disease through earlier detection, improved coordination, and data-driven care delivery. The appointment of Breton as CCO comes at a pivotal time as the company scales its operations and the demand for solutions to rising cardiac spend is at an all-time high. In July, Karoo announced the closing of a $16.2 million Series A financing round co-led by 7wire Ventures and Allumia Ventures, with participation from other marquee investors. "Karoo is at a mission-critical point in our evolution, with unprecedented demand for solutions that address the growing burden of cardiac disease. As we scale our impact nationally, it was essential to bring on a Chief Commercial Officer whose leadership, expertise, and experience reflect where Karoo is today and where we're going. Angie brings exactly that," said Karoo CEO Ian Koons. "Her track record of success and deep understanding of the healthcare ecosystem will help us accelerate our growth and take another significant step toward transforming cardiac care across America." Breton's career spans 25 years as a revenue and commercial growth leader, scaling payer, provider, and healthtech platforms, including commercializing AI-powered clinical products and value-based care delivery models from early product-market fit to national scale. "What drew me to Karoo was the team's clear commitment to solving the real and growing problems in cardiac care and their measurable results for payers, providers, and patients," said Breton. "I'm thrilled to join the team at this inflection point and help drive the next phase of growth as we expand our reach and deepen our impact." Cardiovascular disease remains the leading driver of healthcare costs in the United States. Breton's appointment underscores Karoo's continued investment in the leadership and infrastructure needed to scale as the company strives to make coordinated, data-driven cardiac care the standard, not the exception. About Karoo Health As America's Cardiac Solution(R), Karoo Health is a cardiovascular technology company building the operating system for cardiovascular care. The company connects clinical, claims, pharmacy, and patient data to enable earlier risk detection, coordinated care, improved outcomes, and lower costs. Connect with the company on LinkedIn. SOURCE Karoo Health Inc Posted In:
Karoo Health raises $16.2M to fix cardiac care's fragmentation problem. The Albuquerque-based company already reports a 40% drop in ED visits across deployed programs July 29, 2026 Cardiovascular disease is the top cost driver in US healthcare, and the infrastructure for managing it is a mess. Clinical data lives in one system, claims in another, pharmacy records somewhere else entirely. Karoo Health is betting that building a unifying layer across all of it is both clinically necessary and commercially viable. Investors seem to agree. The company has closed a $16.2 million Series A, co-led by 7wire Ventures and Allumia Ventures, with additional participation from First Trust Capital Partners, SpringRock Ventures, and Hyde Park Angels. The round was oversubscribed. Lee Shapiro of 7wire and Jeff Stolte of Allumia will both join Karoo's board. What Karoo actually does. Karoo describes itself as an operating system for cardiovascular care. It connects clinical, claims, and pharmacy data to support earlier risk detection and care coordination across payers, providers, and patients. The company currently supports more than 600 cardiology providers across 11 states and runs programs with several national and regional health plans. That's a meaningful footprint for a Series A company. And the early numbers are hard to ignore: independent analyses of deployed programs show reductions of more than 40% in ED visits and inpatient admissions, with a greater than 10% reduction in total cost of care across attributed populations. Why the investors moved. 7wire has a track record in consumer-facing digital health, including Livongo, which merged with Teladoc in an $18.5 billion deal. But Karoo's play is more infrastructure than consumer app. Shapiro's framing is pointed: the problem in cardiac care isn't a lack of innovation, it's a system too fragmented to deliver what already exists. Karoo is positioned as the connective layer that lets care teams act on a complete patient picture. What comes next. Proceeds will fund continued development of Karoo's AI-based predictive models and clinical signal detection tools, plus expansion of its engineering and clinical teams. The company also plans to scale payer and provider deployments, with additional health plan launches expected later this year. * Predictive risk model development * Clinical signal detection infrastructure * Expanded engineering and clinical hiring * New payer and provider partnerships For a category where poor coordination routinely leads to avoidable hospitalizations, a platform that demonstrably reduces utilization is a real clinical story, not just a pitch deck claim.
Karoo Health, an Albuquerque, NM-based cardiovascular technology company, raised $16.2M in Series A funding
Karoo Health announces oversubscribed $16.2 million Series A co-led by 7wire Ventures and Allumia Ventures. Jul 21, 2026, 08:50 ET Proceeds will be used to advance the company's AI-native cardiovascular platform and expand partnerships with health plans and cardiology practices nationwide ALBUQUERQUE, N.M., July 21, 2026 /PRNewswire/ - Karoo Health, a cardiovascular technology company building an operating system supporting cardiac care, today announced the closing of a $16.2 million Series A financing round co-led by 7wire Ventures and Allumia Ventures, with participation from First Trust Capital Partners, LLC, SpringRock Ventures, Hyde Park Angels (HPA), and other marquee investors. As part of the financing, Lee Shapiro, Managing Partner at 7wire Ventures, and Jeff Stolte, Managing Partner at Allumia Ventures, will join Karoo's Board of Directors. Karoo is building an operating system for cardiovascular care, a technology platform designed to connect payers, providers, and patients through a unified data and workflow layer that supports earlier risk detection, care coordination, and overall improved cardiovascular disease outcomes. The company's mission is to free people from the pain of cardiovascular disease at scale through earlier detection, improved coordination, and data-driven care delivery. "We're at a seminal moment in our country's fight against cardiovascular disease," said Karoo Health CEO and Cofounder Ian Koons. "We intend to use this capital to take another major step toward becoming the solution that enables every American to access earlier, more coordinated, and more effective cardiovascular care." Cardiovascular disease remains the leading driver of healthcare costs in the United States, and care delivery remains fractured across clinical systems, claims data, pharmacy records, and care teams. This fragmentation contributes to delayed intervention, inconsistent chronic disease management, and avoidable hospital utilization, procedures, and testing. "The challenge in cardiovascular care today isn't a shortage of innovation but a system too fragmented to deliver it consistently," said Lee Shapiro, Managing Partner of 7wire Ventures. "That fragmentation is precisely the kind of problem the right technology can solve. Karoo is creating the connective layer that lets care teams act on a complete picture of each patient, and its deployments are already producing meaningful reductions in avoidable utilization and cost. We are proud to co-lead this round." Today, Karoo supports a network of more than 600 cardiology providers across 11 states, operates programs with leading national and regional health plans and is launching with others later this year. In deployed programs, independent analyses reported reductions of more than 40% in emergency department visits and inpatient admissions, and early results show a greater than 10% reduction in total cost of care throughout attributed populations. "We've been waiting for a company with the technology, clinical vision, and leadership team capable of fundamentally changing how cardiac care is delivered. We believe Karoo Health is that company, and we're proud to support their mission to improve outcomes for patients at scale while helping build a more proactive, connected, and effective model for cardiovascular care," said Jeff Stolte, Managing Partner at Allumia Ventures. Karoo will use proceeds from the financing to further develop its AI-native cardiovascular platform, including continued development of predictive models, clinical signal detection capabilities, and care coordination infrastructure. The company also plans to expand its engineering and clinical teams and continue scaling deployments with payer and provider partners. About Karoo Health Karoo Health is a cardiovascular technology company building the operating system for cardiovascular care. The company connects clinical, claims, pharmacy, and patient data to enable earlier risk detection, coordinated care, improved outcomes, and lower costs. Connect with the company on LinkedIn. About 7wire Ventures 7wire Ventures is a venture capital firm investing in early-stage digital health companies that empower consumers to take greater control of their health and well-being. The firm focuses on technologies that advance a more connected, consumer-centric healthcare ecosystem. Founded by experienced operators and investors, 7wire partners closely with entrepreneurs to build category-defining companies, including Livongo, which merged with Teladoc Health in an $18.5 billion transaction. Through its operator-led approach and network of Strategic Limited Partners, including health plans, health systems, life sciences organizations, and self-insured employers, 7wire helps portfolio companies accelerate growth, expand market access, and drive meaningful innovation across healthcare. For more information, visit www.7wireventures.com. About Allumia Ventures Allumia Ventures is a leading healthcare venture capital firm focused on identifying and investing in best-in-class commercial-stage healthcare companies transforming healthcare through innovative technologies and care models. More than a source of capital, Allumia partners closely with entrepreneurs to accelerate adoption by leveraging deep relationships across the healthcare ecosystem and an extensive network of health systems and industry leaders. With roots in Providence, one of the nation's largest integrated delivery networks, Allumia combines strategic expertise with a disciplined investment approach to help build companies that improve healthcare and deliver lasting impact. Connect with Allumia Ventures at www.allumiaventures.com. SOURCE Karoo Health Inc
Find jobs on Simplify and start your career today
Industries
Company Size
11-50
Company Stage
Series A
Total Funding
$19.6M
Headquarters
Albuquerque, New Mexico
Founded
2021
Find jobs on Simplify and start your career today